WebJun 14, 2024 · Ms. Lenington added, “I am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of helping patients ... WebOct 21, 2024 · Special Committee of the Board of Directors has concluded its investigation of Dr. Leen Kawas’s Doctoral ResearchConference call to be held October 21, 2024 at 4:30 pm ET BOTHELL, Wash., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small …
Athira Pharma on LinkedIn: Today we announced Rachel …
WebRachel Lenington is the Chief Operating Officer at Athira Pharma. Rachel Lenington attended Pepperdine Graziadio Business School. WebWork Biography for Rachel Lenington, Athira Pharma. Rachel Lenington works as a Chief Technology Officer & Head of Product Development Strategy at Athira Pharma, which is a Chemicals & Related Products company with an estimated 20 employees; and founded in … huffpost fox news
Rachel Lenington - Chief Operating Officer - Athira …
WebAug 17, 2024 · In addition to Litton’s appointment, former Seagen exec Rachel Lenington, MBA, has been appointed as the company’s Chief Technology Officer and Head of Product Development Strategy. In addition, Mark Worthington, J.D., was recently appointed as Athira’s General Counsel. WebCurrently, Rachel Lenington occupies the position of Chief Operating Officer at Athira Pharma, Inc. Ms. Lenington previously occupied the position of Director & Manager-Global Program at Amgen, Inc., Senior VP-Program & Portfolio Management at Seagen Inc. and Deputy Director-Strategy, Planning & Management at Bill & Melinda Gates Foundation. WebMar 31, 2024 · The list of insiders at Athira Pharma includes Glenna Mileson, Hans Moebius, James A Johnson, Joseph Edelman, Kelly A Romano, Mark James Litton, Mark Worthington, Perceptive Advisors Llc, and Rachel Lenington. Learn more on insiders at ATHA. huffpost gas prices